Four Fresh-Faced Biopharmas Reel in Millions in Series A Funds

The cash came rolling in for four biopharma companies Thursday morning, with collective Series A rounds totaling more than $125 million.

Exai Raises $67.5 Million for Cancer Detection Platform

Exai Bio raised $67.5 million to bolster efforts to develop its early cancer detection platform.